πŸ‡ΊπŸ‡Έ FDA
Patent

US 10160802

Anti-malarial compositions

granted A61KA61K2039/505A61K39/015

Quick answer

US patent 10160802 (Anti-malarial compositions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K39/015, A61K39/39575, A61K45/06